Annual Working Capital
$548.52 M
-$564.29 M-50.71%
December 31, 2024
Summary
- As of February 26, 2025, RPRX annual working capital is $548.52 million, with the most recent change of -$564.29 million (-50.71%) on December 31, 2024.
- During the last 3 years, RPRX annual working capital has fallen by -$2.16 billion (-79.74%).
- RPRX annual working capital is now -79.74% below its all-time high of $2.71 billion, reached on December 31, 2021.
Performance
RPRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$548.52 M
-$77.91 M-12.44%
December 31, 2024
Summary
- As of February 26, 2025, RPRX quarterly working capital is $548.52 million, with the most recent change of -$77.91 million (-12.44%) on December 31, 2024.
- Over the past year, RPRX quarterly working capital has dropped by -$564.29 million (-50.71%).
- RPRX quarterly working capital is now -83.49% below its all-time high of $3.32 billion, reached on June 30, 2022.
Performance
RPRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RPRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.7% | -50.7% |
| 3 y3 years | -79.7% | -50.7% |
| 5 y5 years | +10.0% | -50.7% |
RPRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.7% | at low | -83.5% | at low |
| 5 y | 5-year | -79.7% | +10.0% | -83.5% | +10.0% |
| alltime | all time | -79.7% | +10.0% | -83.5% | +10.0% |
Royalty Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $548.52 M(-50.7%) | $548.52 M(-12.4%) |
| Sep 2024 | - | $626.44 M(-72.8%) |
| Jun 2024 | - | $2.30 B(+60.5%) |
| Mar 2024 | - | $1.44 B(+29.0%) |
| Dec 2023 | $1.11 B(-19.8%) | $1.11 B(-30.5%) |
| Sep 2023 | - | $1.60 B(-10.1%) |
| Jun 2023 | - | $1.78 B(+17.6%) |
| Mar 2023 | - | $1.51 B(+9.1%) |
| Dec 2022 | $1.39 B | $1.39 B(+14.7%) |
| Sep 2022 | - | $1.21 B(-63.6%) |
| Jun 2022 | - | $3.32 B(+16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.85 B(+5.2%) |
| Dec 2021 | $2.71 B(+13.3%) | $2.71 B(+7.4%) |
| Sep 2021 | - | $2.52 B(+4.0%) |
| Jun 2021 | - | $2.42 B(+12.2%) |
| Mar 2021 | - | $2.16 B(-9.6%) |
| Dec 2020 | $2.39 B(+379.1%) | $2.39 B(-5.0%) |
| Sep 2020 | - | $2.51 B(-14.5%) |
| Jun 2020 | - | $2.94 B(+125.5%) |
| Mar 2020 | - | $1.30 B(+161.5%) |
| Dec 2019 | $498.65 M(-75.4%) | $498.65 M |
| Dec 2018 | $2.03 B | - |
FAQ
- What is Royalty Pharma annual working capital?
- What is the all time high annual working capital for Royalty Pharma?
- What is Royalty Pharma annual working capital year-on-year change?
- What is Royalty Pharma quarterly working capital?
- What is the all time high quarterly working capital for Royalty Pharma?
- What is Royalty Pharma quarterly working capital year-on-year change?
What is Royalty Pharma annual working capital?
The current annual working capital of RPRX is $548.52 M
What is the all time high annual working capital for Royalty Pharma?
Royalty Pharma all-time high annual working capital is $2.71 B
What is Royalty Pharma annual working capital year-on-year change?
Over the past year, RPRX annual working capital has changed by -$564.29 M (-50.71%)
What is Royalty Pharma quarterly working capital?
The current quarterly working capital of RPRX is $548.52 M
What is the all time high quarterly working capital for Royalty Pharma?
Royalty Pharma all-time high quarterly working capital is $3.32 B
What is Royalty Pharma quarterly working capital year-on-year change?
Over the past year, RPRX quarterly working capital has changed by -$564.29 M (-50.71%)